ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
דקפפטיל דפו 3.75 מג
ferring pharmaceuticals ltd - triptorelin as embonate - suspension for injection - triptorelin as embonate 3.75 mg ml - triptorelin - triptorelin - lowering of sexual hormones and treatment of advanced prostate cancer. central precocious puberty.
דקפפטיל דפו 11.25 מג
ferring pharmaceuticals ltd - triptorelin as embonate - suspension for injection - triptorelin as embonate 11.25 mg - triptorelin - triptorelin - prostatic cancer and lowering of sexual hormones.
ארלידה
j-c health care ltd - apalutamide - טבליות מצופות פילם - apalutamide 60 mg - apalutamide
דקפפטיל דפו 22.5 מג
ferring pharmaceuticals ltd - triptorelin as embonate - אבקה וממס להכנת תרחיף להזרקה - triptorelin as embonate 22.5 mg - triptorelin
לינפארזה 100 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib
לינפארזה 100 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib
לינפארזה 150 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib
לינפארזה 150 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib
סופרפאקט דפו 3 חודשים
sanofi - aventis israel ltd - buserelin acetate - קנים להשתלה - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).